Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna de Andrade Pereira

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Discovery Medicine|October 15, 2015
Novel immunotherapeutic approaches in targeting dendritic cells with virus vectorsBruna de Andrade Pereira, Cornel Fraefel
The Open Virology Journal|November 14, 2013
Viral and Cellular Components of AAV2 Replication CompartmentsRebecca Vogel, Michael Seyffert, Bruna de Andrade Pereira, et al.
European Journal of Immunology|July 13, 2011
Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factorsChristiane Dresch, Mathias Ackermann, Bernd Vogt, et al.
Plos One|December 19, 2015
Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in MiceBruna de Andrade Pereira, Leoneide E Maduro Bouillet, Natalia A Dorigo, et al.
Journal of Virology|May 19, 2017
Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1Francesca D Franzoso, Michael Seyffert, Rebecca Vogel, et al.
Molecular Cancer Therapeutics|September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine PathwayMelanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Discovery Medicine|October 15, 2015
Novel immunotherapeutic approaches in targeting dendritic cells with virus vectorsBruna de Andrade Pereira, Cornel Fraefel
The Open Virology Journal|November 14, 2013
Viral and Cellular Components of AAV2 Replication CompartmentsRebecca Vogel, Michael Seyffert, Bruna de Andrade Pereira, et al.
European Journal of Immunology|July 13, 2011
Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factorsChristiane Dresch, Mathias Ackermann, Bernd Vogt, et al.
Plos One|December 19, 2015
Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in MiceBruna de Andrade Pereira, Leoneide E Maduro Bouillet, Natalia A Dorigo, et al.
Journal of Virology|May 19, 2017
Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1Francesca D Franzoso, Michael Seyffert, Rebecca Vogel, et al.
Molecular Cancer Therapeutics|September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine PathwayMelanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Pageof 1